The purpose of this trial is to allow patients who are currently on the PROSERA trial to receive medication until the study drug is commercially available.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Jimmy Ford
Medicine-Pulmonary
Clinical or Medical
Interventional
Blood Pressure
Genetics and Genetic Disorders
Lungs and Breathing
Rare Diseases
24-2399
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
